Supplementary Materials

This PDF file includes:

  • Fig. S1. Classification of the test cohort patients according to PERSEVERE.
  • Fig. S2. Classification of the test cohort mice according to the derived mPERSEVERE.
  • Fig. S3. Ten-day survival curves of mice challenged with CLP and then randomized to treatment with an anti-CCL3 antibody or an isotype control antibody.
  • Table S1. Demographic and clinical characteristics of the study cohort according to 28-day survival.
  • Table S2. Comparison of illness severity measures among true-negative and false-positive subjects.
  • Table S3. Calculation of the NNT.

[Download PDF]